BRIDGEBIO PHARMA INC

Ticker: BBIO CUSIP: 10806X102 Class: EQTY

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 74,686 Value ($000) $5,713 Avg Close $65.64 Range $51.85 - $78.44
Q3 2025
Shares 101,242 Value ($000) $5,259 Avg Close $48.77 Range $41.80 - $54.60
Q2 2025
Shares 422,715 Value ($000) $18,253 Avg Close $36.37 Range $28.32 - $45.48
Q1 2025
Shares 421,859 Value ($000) $14,584 Avg Close $33.72 Range $27.53 - $39.47
Q4 2024
Shares 827,958 Value ($000) $22,719 Avg Close $25.84 Range $21.72 - $30.51
Q3 2024
Shares 833,236 Value ($000) $21,214 Avg Close $26.25 Range $23.40 - $32.06
Q2 2024
Shares 30,849 Value ($000) $781 Avg Close $27.34 Range $21.62 - $31.43
Q4 2023
Shares 37,897 Value ($000) $1,530 Avg Close $30.03 Range $23.62 - $44.32
Q3 2023
Shares 162,916 Value ($000) $4,296 Avg Close $28.38 Range $16.61 - $36.36
Q1 2023
Shares 1,084,595 Value ($000) $17,983 Avg Close $11.66 Range $7.10 - $19.95
Q3 2022
Shares 71,245 Value ($000) $708 Avg Close $10.39 Range $6.55 - $12.64
Q4 2021
Shares 290,362 Value ($000) $4,843 Avg Close $42.31 Range $11.20 - $53.57
Q3 2021
Shares 15,519 Value ($000) $727 Avg Close $53.60 Range $46.68 - $65.33
Q1 2021
Shares 75,995 Value ($000) $4,681 Avg Close $65.42 Range $54.35 - $73.50